<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Patient Instructions</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Results</a></li><li><a href="#id9">Visit Diagnoses</a></li><li><a href="#id10">Additional Health Concerns</a></li><li><a href="#id11">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td ID="rfv2comments">Malignant neoplasm of central portion of right breast in female, estrogen receptor positive</td></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>[REDACTED] 10:50 AM EDT</td><td ID="encounter3type">Office Visit</td><td><p>UHealth Breast Oncology at Plantation</p><p>[REDACTED]</p><p>2nd Floor</p><p>PLANTATION, FL 33324</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>3rd Floor</p><p>Plantation, FL 33324-3279</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Malignant neoplasm of central portion of right breast in female, estrogen receptor positive (CMS/HCC) (Primary Dx); <br/>Malignant neoplasm of breast in female, estrogen receptor positive, unspecified laterality, unspecified site of breast (CMS/HCC); <br/>Invasive ductal carcinoma of right breast in female (CMS/HCC)</content><br/>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist9"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist9packsperday"/><td/><td/></tr><tr ID="sochist9smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist9cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Not Answered<br/><span class="xcellHeader">Comments:</span> social drinker <br/></td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>3 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess1"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>AUDIT-C</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess1pair1"><td ID="sdohassess1pair1ques">Q1: How often do you have a drink containing alcohol?</td><td ID="sdohassess1pair1ans">2-3 times a week</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair2"><td ID="sdohassess1pair2ques">Average Number of Drinks</td><td ID="sdohassess1pair2ans">Not on file</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair3"><td ID="sdohassess1pair3ques">Frequency of Binge Drinking</td><td ID="sdohassess1pair3ans">Not on file</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess3"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess3pair1"><td ID="sdohassess3pair1ques">PHQ-9 Total Score</td><td ID="sdohassess3pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Pregnant</th><th>Comments</th></tr></thead><tbody><tr><td>No</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex12"><td>Sex Assigned at Birth</td><td ID="BirthSex12Value">Female</td><td>[REDACTED]  6:53 AM EST</td></tr><tr ID="LegalSex13"><td>Legal Sex</td><td ID="LegalSex13Value">Female</td><td>[REDACTED]  8:30 PM EDT</td></tr><tr ID="GenderIdentity10"><td>Gender Identity</td><td ID="GenderIdentity10Value">Female</td><td>[REDACTED]  6:53 AM EST</td></tr><tr ID="SexualOrientation11"><td>Sexual Orientation</td><td ID="SexualOrientation11Value">Straight</td><td>[REDACTED]  6:53 AM EST</td></tr></tbody></table><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Occupation</th><th>Industry</th><th>Job Start Date</th><th>Job End Date</th></tr></thead><tbody><tr ID="Occupation14"><td ID="Occupation14Value">Retired</td><td ID="Industry14Value">Not on file</td><td>Not on file</td><td>Not on file</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">152</span>/<span class="content_span">79</span></td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="pulse_5792221620" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>66</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="temp_5792221620" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>35.9 °C (96.7 °F)</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="resp_5792221620" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>20</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="SpO2_5792221620" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>99%</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5792221620" class="xRowNormal"><td class="xcellHeader">Weight</td><td>83 kg (183 lb)</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="height_5792221620" class="xRowAlt"><td class="xcellHeader">Height</td><td>167.6 cm (5' 6")</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr><tr ID="bmi_5792221620" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>29.54</td><td>[REDACTED] 10:27 AM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED][REDACTED], [REDACTED], RN - [REDACTED] 10:50 AM EDT</span></p><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>[REDACTED]:<br/>--Labs (done)<br/>--CTU - ZOMETA [REDACTED]<br/><br/>Follow-Up:<br/>-- [REDACTED] Lab + OV + CTU ZOMETA <br/><br/>Other:<br/>--Breast Imaging: mammogram due [REDACTED] already scheduled <br/>--Other Imaging: NONE<br/>--Referrals: NONE<br/><br/>If you have any questions or concerns regarding your appointment or if you need to reach the office, please see below:<br/><br/>Dr. Breast Team Contact Information<br/><br/>TRIAGE NURSE: [REDACTED]<br/>Symptom management <br/>Test Results (imaging/blood work/biopsy results) <br/>Prescription Refills<br/><br/>ADMINISTRATIVE ASSISTANT: [REDACTED] opt 5 <br/>General administrative questions for the physician<br/>Work related forms: FMLA, disability<br/><br/>CTU: [REDACTED]<br/>For treatment related appointments<br/><br/> If you need to contact your physician, please e-mail them via the MyUHealthChart.com website.  <br/> <br/>If you have any questions regarding your MyUHealthChart, please send all concerns to the e-mail: [REDACTED]. <br/> <br/>This information is also available, for patients, by visiting MyUHealthChart.com:<br/>1. Click on "Frequently Asked Questions"<br/>2. If you have a MyUHealthChart account and are able to access it, you may e-mail correspondence via your "Message Center" tab by clicking on "Ask Customer Service" and creating an e-mail. <br/> <br/>    A. Click on "Message Center"<br/>    B. Click on "Ask Customer Service"<br/>    C. Create correspondence<br/>    D. Click on "Inbox" to review technical support issue response.<br/><br/>Thank you for the opportunity to serve and care for you. <br/>Your opinions are valued. Please respond to our patient survey if you receive one in the mail.<br/> <br/> <br/>UHealth Patient and Visitor Services <br/>Phone: [REDACTED] (4357) <br/>Email: [REDACTED] <br/>  <br/><br/>[REDACTED]:<br/>--Labs ([REDACTED] )<br/>--CTU - ZOMETA [REDACTED] (EVERY 6 MONTHS ) <br/><br/>Follow-Up:<br/><br/>--OV + Lab [REDACTED] -ZOMETA EVERY 6 MONTHS <br/><br/>Other:<br/>--Breast Imaging: mammogram due [REDACTED] already scheduled <br/>--Other Imaging:<br/>--Referrals:<br/><br/>Orders Placed This Encounter <br/>Procedures <br/> Cancer antigen 15-3 <br/> Cancer antigen 27.29 <br/> CBC and differential <br/> Comprehensive metabolic panel <br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], [REDACTED], APRN MSN at [REDACTED] 11:17 AM EDT</span><br/><span class="xLabel">Electronically signed by [REDACTED], APRN MSN at [REDACTED] 11:19 AM EDT</span><br/><span class="xLabel">Electronically signed by [REDACTED], APRN MSN at [REDACTED] 11:21 AM EDT</span><br/><span class="xLabel">Electronically signed by San [REDACTED], [REDACTED], RN at [REDACTED] 11:33 AM EDT</span><br/><span class="xLabel">Electronically signed by San [REDACTED], [REDACTED], RN at [REDACTED] 11:34 AM EDT</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED] 10:50 AM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>[REDACTED] Breast Program at Plantation<br/>Follow up<br/><br/>Name: [REDACTED]<br/>Date of Birth: [REDACTED]<br/>Medical Record Number: [REDACTED] <br/>[REDACTED] Date: [REDACTED] <br/><br/>Chief Complaint <br/>Patient presents with <br/> Follow-up <br/>  Malignant neoplasm of central portion of right breast in female, estrogen receptor positive <br/><br/> Cancer Staging <br/>Malignant neoplasm of central portion of right female breast (HCC)<br/>Staging form: Breast, AJCC 8th Edition<br/>- Clinical stage from [REDACTED]: Stage IA (cT1, cN0, cM0, G1, ER+, PR+, HER2: Equivocal) - Signed by [REDACTED], [REDACTED], APRN MSN on [REDACTED]<br/>Staging comments: From Bx done [REDACTED]<br/><br/>History and Diagnosis: <br/>[REDACTED] is a [REDACTED]. woman  initially diagnosed in [REDACTED] with left breast cancer<br/>She is s/p Left breast mastectomy in [REDACTED] with Dr. [REDACTED] and left breast reconstruction in [REDACTED].<br/>She had a reoccurrence in the left breast in the fall of 1991.<br/>She underwent a Left lumpectomy in fall 1991 and [REDACTED] she completed radiation therapy. <br/>She initiated endocrine therapy with Tamoxifen, completed 15 years in [REDACTED]. This was her last follow up with oncology<br/>On [REDACTED] she underwent a bilateral tomosynthesis screening mammogram with CAD and results yield 7mmn non calcified focal asymmetry in the right upper outer quadrant posterior third BIRADS:0. Needs additional imaging and spot compression CC and MLO views of right breast and right breast ultrasound. <br/>[REDACTED] Unilateral right ultrasound was done and findings of subcentemeter spiculated mass suspicious for malignancy BIRADS:5 highly suggestive of malignancy and recommendation for US guided biopsy. <br/>[REDACTED] She had Right breast biopsy at The Women's Diagnostic Center [REDACTED] andscans done at [REDACTED]. The pathology yielded invasive ductal carcinoma with lobular features, well differentiated Nottingham grade 1 (3+1+1=5)measuring 0.8cm in greatest linear microscopic dimension, ER &gt;50% , PR&gt;50%, HER2neu 2+ and FISH. <br/>Family history: mother breast cancer left diagnosed 69 years, maternal cousin breast cancer 40's . <br/>The Invitae 84-gene panel from 2/2022 showed a pathogenic variant of the BRCA2  c.8297del (p.Thr2766Asnfs*11) and VUS of the MSH3 c.1910A (p.Glu637Ala) gene.<br/> Right breast lumpectomy pathology from [REDACTED] showed invasive mammary carcinoma, with mixed ductal and lobular features, Nottingham grade 1 (3+1+1=5), measures 11 mm; DCIS, nuclear grade 2, solid type; 1/5 lymph nodes positive for metastatic carcinoma (3 mm deposit); pathologic staging pT1cpN1<br/> She underwent Right breast margin lumpectomy on [REDACTED] with [REDACTED]; Invasive mammary carcinoma, with mixed ductal and lobular features, Nottingham grade 1 (3+1+1=5), measures 11 mm. DCIS, nuclear grade 2, solid type. Invasive carcinoma if focally present at anterior margin (in a less than 1mm focus) and DCIS is located &gt;5 from the closest (anterior) margin. <br/> The Oncotype Dx analysis on specimen showed a recurrence score of 20, a 17% risk of distant recurrence at [REDACTED] years with AI or tamoxifen use, with consideration of benefit from chemotherapy not excluded. <br/> She underwent a Left mid temple biopsy on [REDACTED]. Pathology showed MELANOMA IN SITU, transected at the peripheral edges of the biopsy. She underwent a  wide local excision of left mid temple melanoma, with 5 mm margins on [REDACTED] with Dr. Crystal. <br/><br/>Treatment summary:<br/>Surgery:  Right breast lumpectomy -03/08/22 &amp; right breast margin lumpectomy- [REDACTED] <br/>Radiation: Right XRT- completed [REDACTED]<br/>Endocrine therapy:  <br/>Letrozole <br/> Start: [REDACTED]   Stop: <br/>Bone modifying agents:<br/>Zometa<br/> Start: [REDACTED]  Stop:<br/><br/>Interim history: <br/>[REDACTED] is here [REDACTED] to follow up with her initially diagnosed Left breast cancer in [REDACTED] and Right  Breast invasive mammary carcinoma in [REDACTED].<br/>She continues treatment with Letrozole and Zometa which she tolerates well.  Her 4th Zometa injection was completed on [REDACTED] and is scheduled for her 5th injection [REDACTED], [REDACTED]. <br/><br/>[REDACTED] she reports feeling overall well and has completed various surgeries for mole removals.<br/><br/>DEXA scan from [REDACTED] showed osteopenia with a T-score of -1.8, previously -1.7. FRAX 10-year probability of fracture based on provided information and risk factors is: 15% major osteoporotic fracture and 43% hip fracture.<br/><br/>Patient is scheduled for a Right MAM for [REDACTED]. <br/><br/>Patient Active Problem List <br/> Diagnosis Date Noted <br/> Skin lesion [REDACTED] <br/> [REDACTED] in situ of temple region (HCC)  <br/> History of osteopenia [REDACTED] <br/> Genetic testing of female [REDACTED] <br/> Breast mass, right [REDACTED] <br/> Malignant neoplasm of central portion of right female breast (HCC) [REDACTED] <br/> History of left breast cancer [REDACTED] <br/><br/>Gynecological History: <br/>GPA:<br/>Age at Menarche:<br/>Age at first pregnancy:<br/>LMP:<br/><br/>Cancer Screenings:<br/>Last skin exam:<br/>Last colonoscopy:<br/>Smoking cessation counseling (y/n): <br/><br/>There are no preventive care reminders to display for this patient.<br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Breast cancer (HCC) 1987 and 1991 <br/> left breast  <br/> Breast mass, right [REDACTED] <br/> Cataract  <br/> COPD (chronic obstructive pulmonary disease) (HCC)  <br/> Dupuytren contracture  <br/> GERD (gastroesophageal reflux disease)  <br/> Glaucoma  <br/> History of left breast cancer [REDACTED] <br/> 1987 left breast cancer dx at age [REDACTED] multifocal Tx left mastectomy no lymph nodes removed No radiation, no hormonal tx 1991 recurrence in same breast  Surgery, radiation and reconstruction Tamoxifen from [REDACTED]-[REDACTED]    <br/> Invasive ductal carcinoma of right breast in female (HCC) [REDACTED] <br/> Bx done [REDACTED] Broward Health [REDACTED]  <br/> Knee pain  <br/> Neuropathy  <br/> Retinal detachment  <br/> Skin cancer (melanoma) (HCC)  <br/> temple left side 10/2023 <br/> UTI (urinary tract infection) [REDACTED] <br/><br/> <br/>Past Surgical History: <br/>Procedure Laterality Date <br/> ANKLE SURGERY Right early 1970's <br/> fusion after ankle break  <br/> BREAST ENHANCEMENT SURGERY  1988 <br/> BREAST RECONSTRUCTION Left  <br/> BREAST SURGERY Left  <br/> mastectomy and lumpectomy <br/> CATARACT REMOVAL Right 1970 <br/> EYE SURGERY   <br/> HYSTERECTOMY  1990's <br/> MASTECTOMY Left  <br/> 1987 <br/> PR BX OF BREAST, NEEDLE CORE, IMAGE GUIDE   <br/> PR BX/EXC LYMPH NODE OPEN DEEP AXILLARY NODE Right [REDACTED] <br/> Procedure: BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, DEEP AXILLARY NODE(S) POSSIBLE AXILLARY DISSECTION;  Surgeon: [REDACTED], MD;  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR EXC CYST/ABERRANT BREAST TISSUE OPEN 1/&gt; LESION   <br/> PR EXCISION MAL LESION TRUNK/ARM/LEG 1.1-2.0 CM Left [REDACTED] <br/> Procedure: WIDE LOCAL EXCISION OF TEMPLE SKIN LESION (LEFT);  Surgeon: [REDACTED], [REDACTED], MD;  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR EXCISION MALIGNANT LESION TRUNK/ARM/LEG &gt; 4.0 CM Left [REDACTED] <br/> Procedure: WIDE LOCAL EXCISION OF SQUAMOUS CELL CARCINOMA OF LEFT UPPER EXTREMITY;  Surgeon: Crystal, [REDACTED], MD;  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR INJ RADIOACTIVE TRACER FOR ID OF SENTINEL NODE Right [REDACTED] <br/> Procedure: INJECTION PROCEDURE; FOR IDENTIFICATION OF SENTINEL NODE AND ALL OTHER INDICATED PROCEDURES;  Surgeon: [REDACTED], [REDACTED];  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR MASTECTOMY PARTIAL Right [REDACTED] <br/> Procedure: RIGHT BREAST NEEDLE LOCALIZED LUMPECTOMY WITH RIGHT SENTINEL LYMPH NODE BIOPSY;  Surgeon: [REDACTED], [REDACTED];  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR MASTECTOMY PARTIAL Right [REDACTED] <br/> Procedure: RIGHT BREAST MARGIN LUMPECTOMY RE-EXCISION;  Surgeon: [REDACTED], [REDACTED];  Location: SCCC OR;  Service: Surgical Oncology <br/> PR REPAIR INTERMEDIATE F/E/E/N/L&amp;/MUC 2.5 CM/&lt; Left [REDACTED] <br/> Procedure: REPAIR, INTERMEDIATE, WOUNDS OF LEFT FACE,  ;  Surgeon: Crystal, [REDACTED], [REDACTED];  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> PR REPAIR INTERMEDIATE S/A/T/E 12.6-20.0CM Left [REDACTED] <br/> Procedure: REPAIR, INTERMEDIATE ARM, all other indicated procedures;  Surgeon: [REDACTED], [REDACTED], MD;  Location: UMH MAIN OR;  Service: Surgical Oncology <br/> RADIATION   <br/> RETINAL DETACHMENT REPAIR  2010 <br/><br/>Family History <br/>Problem Relation Age of Onset <br/> Emphysema Mother  <br/> Breast cancer Mother [REDACTED] <br/> No Known Problems Father  <br/> Breast cancer Maternal cousin [REDACTED] <br/><br/> <br/>Social History <br/><br/>Tobacco Use <br/> Smoking status: Never <br/> Smokeless tobacco: Never <br/> Tobacco comments: <br/>  social drinker  <br/>Vaping Use <br/> Vaping Use: Never used <br/>Substance Use Topics <br/> Alcohol use: Yes <br/>  Alcohol/week: 3.0 standard drinks of alcohol <br/>  Types: 3 Drinks containing 0.5 oz of alcohol per week <br/> Drug use: Never <br/>  <br/><br/>Allergies <br/>Allergen Reactions <br/> Sulfamethoxazole-Trimethoprim Rash <br/><br/>Current Outpatient Medications on File Prior to Visit <br/>Medication Sig Dispense Refill <br/> acetaminophen (Tylenol) 325 MG tablet Take 2 tablets by mouth every 4 hours as needed for Pain for up to 15 days. 180 tablet 0 <br/> ibuprofen (MOTRIN) 600 MG tablet Take 1 tablet by mouth every 6 hours as needed for Pain for up to 15 days. 60 tablet 0 <br/> celecoxib (CeleBREX) 200 MG capsule Take 200 mg by mouth daily.   <br/> senna-docusate (PERICOLACE) 8.6-50 MG per tablet Take 1 tablet by mouth daily.   <br/> Vibegron (Gemtesa) 75 MG TABS Take  by mouth.   <br/> Trelegy Ellipta 200-62.5-25 MCG/ACT AEPB INHALE 1 PUFF BY MOUTH IN THE MORNING RINSE MOUTH AFTER USE   <br/> albuterol HFA 108 (90 Base) MCG/ACT inhaler Inhale 2 puffs into the lungs every 6 hours as needed for Wheezing.   <br/> omeprazole (PriLOSEC) 40 MG capsule TAKE 1 CAPSULE BY MOUTH ONCE DAILY 30 MINUTES BEFORE MORNING MEAL   <br/><br/>No current facility-administered medications on file prior to visit. <br/> <br/><br/>Review of Systems <br/>Constitutional:  Negative for activity change, appetite change, chills, fatigue, fever and unexpected weight change. <br/>HENT:  Negative for congestion, ear pain, hearing loss and mouth sores.  <br/>Eyes:  Negative for pain, discharge and redness. <br/>Respiratory:  Negative for cough, chest tightness and shortness of breath.  <br/>Cardiovascular:  Negative for chest pain, palpitations and leg swelling. <br/>Gastrointestinal:  Negative for abdominal distention, abdominal pain, nausea and vomiting. <br/>Endocrine: Negative for polydipsia, polyphagia and polyuria. <br/>Genitourinary:  Negative for flank pain, frequency and urgency. <br/>Musculoskeletal:  Negative for back pain, joint swelling and neck stiffness. <br/>Skin:  Negative for rash and wound. <br/>Neurological:  Negative for seizures, facial asymmetry and speech difficulty. <br/>Hematological:  Negative for adenopathy. <br/>Psychiatric/Behavioral:  Negative for behavioral problems, confusion and hallucinations.  <br/><br/>Vitals: <br/> [REDACTED] 1027 <br/>BP: 152/79 <br/>Pulse: 66 <br/>Resp: 20 <br/>Temp: 96.7 °F (35.9 °C) <br/><br/> <br/><br/>Physical Exam<br/>Constitutional:  <br/>   Appearance: She is well-developed. <br/>   Comments: ECOG-0 <br/>HENT: <br/>   Head: Normocephalic and atraumatic. <br/>Eyes: <br/>   Conjunctiva/sclera: Conjunctivae normal. <br/>Neck: <br/>   Thyroid: No thyromegaly. <br/>   Trachea: No tracheal deviation. <br/>Cardiovascular: <br/>   Rate and Rhythm: Normal rate and regular rhythm. <br/>   Heart sounds: Normal heart sounds. <br/>Pulmonary: <br/>   Breath sounds: Normal breath sounds. <br/>Abdominal: <br/>   General: Bowel sounds are normal. <br/>   Palpations: Abdomen is soft. <br/>Musculoskeletal:    <br/>   General: Normal range of motion. <br/>   Cervical back: Normal range of motion and neck supple. <br/>Skin:<br/>   General: Skin is warm. <br/>Neurological: <br/>   Mental Status: She is alert and oriented to person, place, and time. <br/>Psychiatric:    <br/>   Judgment: Judgment normal. <br/><br/>Breast Exam:<br/>Left mastectomy scar with implant. <br/>Post lumpectomy changes right breast, no abnormalities of concern<br/>Temporal skin incision with yellow discharge<br/><br/>Labs:<br/>  Chemistry  <br/>  <br/>Component Value Date/Time <br/> NA 142 [REDACTED] 0946 <br/> K 4.2 [REDACTED] 0946 <br/> CL 107 [REDACTED] 0946 <br/> CO2 30 [REDACTED] 0946 <br/> CO2 27 [REDACTED] 1720 <br/> BUN 20 [REDACTED] 0946 <br/> BUN 18 [REDACTED] 1720 <br/> GLU 87 [REDACTED] 0946 <br/>   <br/>Component Value Date/Time <br/> AST 12 [REDACTED] 0946 <br/> AST 13 [REDACTED] 1720 <br/> ALT 6 [REDACTED] 0946 <br/> ALT 11 [REDACTED] 1720 <br/> <br/><br/>Lab Results <br/>Component Value Date <br/> GLU 87 [REDACTED] <br/> [REDACTED] 9.7 [REDACTED] <br/> ALB 3.9 [REDACTED] <br/> NA 142 [REDACTED] <br/> K 4.2 [REDACTED] <br/> CO2 30 [REDACTED] <br/> CL 107 [REDACTED] <br/> BUN 20 [REDACTED] <br/> CREAT 0.79 [REDACTED] <br/> ALT 6 [REDACTED] <br/> AST 12 [REDACTED] <br/><br/>Lab Results <br/>Component Value Date <br/> CA153 15.2 [REDACTED] <br/> CEA 1.2 [REDACTED] <br/><br/>Imaging:<br/><br/>DEXA Scan: [REDACTED]<br/>FINDINGS: <br/> <br/>Lumbar Spine L1-L4:<br/>BMD g/cm2: 0.884<br/>T-Score: -1.5<br/>Prior BMD: 0.881<br/>BMD change versus previous: 0.3%<br/> <br/>Left Femoral Neck:<br/>BMD g/cm2: 0.644<br/>T-Score: -1.8<br/> <br/>Total Left Hip:<br/>BMD g/cm2: 0.842<br/>T-Score: -0.8<br/>Prior BMD: 0.854<br/>BMD change versus previous: -1.4%<br/> <br/>IMPRESSION:<br/>1. The patient has osteopenia, according to the lowest T-score above. <br/>2. FRAX 10-year probability of fracture based on provided information and risk factors is: 15% major osteoporotic fracture and 43% hip fracture.<br/> <br/><br/>DIGITAL DIAGNOSTIC RIGHT MAMMOGRAM WITH TOMOSYNTHESIS MAMMOGRAPHY: [REDACTED] <br/>IMPRESSION:<br/>Stable post treatment changes of the right breast. In the absence of new clinical findings the patient is due for a right mammogram [REDACTED].<br/>FINAL ASSESSMENT: BI-RADS 2: Benign<br/><br/> <br/><br/>Assessment and Plan : <br/>[REDACTED] is a [REDACTED]. woman initally dx left breast cancer in [REDACTED], s/p left breast mastectomy in [REDACTED] with Dr. [REDACTED] and left breast reconstruction in [REDACTED]. <br/>She had a reoccurrence in the left breast, s/p left lumpectomy in fall 1991 &amp; completed XRT in [REDACTED]<br/>She completed 15 years of treatment with Tamoxifen in [REDACTED]. TX well tolerated. This was her last follow up with oncology<br/>On [REDACTED] she underwent a bilateral tomosynthesis screening mammogram with CAD and results yield 7mmn non calcified focal asymmetry in the right upper outer quadrant posterior third BIRADS:0. Needs additional imaging and spot compression CC and MLO views of right breast and right breast ultrasound. <br/>[REDACTED] Unilateral right ultrasound was done and findings of subcentemeter spiculated mass suspicious for malignancy BIRADS:5 highly suggestive of malignancy and recommendation for US guided biopsy. <br/>[REDACTED] She had Right breast biopsy at The Women's Diagnostic Center [REDACTED] andscans done at [REDACTED]. The pathology yielded invasive ductal carcinoma with lobular features, well differentiated Nottingham grade 1 (3+1+1=5)measuring 0.8cm in greatest linear microscopic dimension, ER &gt;50% , PR&gt;50%, HER2neu 2+ and FISH. <br/>The Invitae 84-gene panel from 2/2022 showed a pathogenic variant of the BRCA2  c.8297del (p.Thr2766Asnfs*11) and VUS of the MSH3 c.1910A (p.Glu637Ala) gene.<br/> MAM US Breast Right Core Axillary Lymph Node Biopsy from [REDACTED] showed fibroadipose tissue with a single atrophic lobule and a 2 mm focus of fibrous stroma. <br/>Right breast lumpectomy pathology from [REDACTED] showed invasive mammary carcinoma, with mixed ductal and lobular features, Nottingham grade 1 (3+1+1=5), measures 11 mm; DCIS, nuclear grade 2, solid type; 1/5 lymph nodes positive for metastatic carcinoma (3 mm deposit); pathologic staging pT1cpN1a<br/> The Oncotype Dx analysis showed a recurrence score of 20, a 17% risk of distant recurrence at [REDACTED] years with AI or tamoxifen use, with consideration of benefit from chemotherapy not excluded.<br/> She completed radiation therapy to right breast with [REDACTED] on [REDACTED]. <br/>On [REDACTED] she was found to have melanoma on her left temple. <br/> She underwent a Left mid temple biopsy on [REDACTED]. Pathology showed MELANOMA IN SITU, transected at the peripheral edges of the biopsy. She underwent a  wide local excision of left mid temple melanoma, with 5 mm margins on [REDACTED] with Dr. Crystal. <br/><br/>[REDACTED] is a [REDACTED]. female with pT1cpN1a right breast cancer with a hx of left breast cancer dx in [REDACTED] in the context of a BRCA2 mutation. <br/><br/>She will continue endocrine therapy with Letrozole which she tolerates well.  She will also continue treatment with Zometa every 6 months for 3 years [REDACTED], her 5th injection will be due in [REDACTED].<br/><br/>She will continue to be monitored under increased surveillance with regular breast exams and symptom-based imaging. <br/>We will continue to monitor her bone mineral density with DEXA scan, next scan due [REDACTED]. It is also recommended that she take Vitamin D + Calcium supplements,  also recommend isometric exercises or weight baring exercises. <br/><br/>She also knows to follow a low-fat, high- fiber diet, exercise 30 minutes a day or an hour every other day.<br/>The patient knows to follow up with her primary care physician and gynecologist for all age and gender appropriate screenings. <br/><br/>All her questions were addressed to her satisfaction in [REDACTED] visit and she knows she can call us with any questions/concerns. <br/>She will return for an office visit [REDACTED].<br/><br/>Orders Placed This Encounter <br/>Procedures <br/> Cancer antigen 15-3 <br/> Cancer antigen 27.29 <br/> CBC and differential <br/> Comprehensive metabolic panel <br/> CEA <br/><br/>I [REDACTED] am serving as a scribe to document services personally performed by [REDACTED], MD  based upon the provider's statements to me. All documentation has been reviewed by the aforementioned doctor prior to being entered into the official medical record.<br/><br/>Electronically signed by:<br/>[REDACTED] , Scribe<br/>[REDACTED]  11:34 AM<br/>Provider Attestation:<br/>I, [REDACTED], [REDACTED], personally performed the services described in this documentation. All medical record entities made by the scribe were at my direction and in my presence. I have reviewed the chart and agree that the record reflects my personal performance and is accurate and complete.<br/><br/>Electronically Signed:<br/>[REDACTED], MD<br/>[REDACTED] 9:47 PM<br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], [REDACTED] at [REDACTED]  9:47 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter39" class="xRowNormal"><td>[REDACTED]  3:40 PM EDT</td><td ID="encounter39type">Office Visit</td><td><p>UHealth Tower: Plastic Surgery Clinic at [REDACTED] and Clinics -</p><p>[REDACTED]</p><p>STE 200</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]-1673</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter38" class="xRowAlt"><td>[REDACTED]  9:30 AM EDT</td><td ID="encounter38type">Appointment</td><td><p>UHealth Breast Lab at Plantation</p><p>[REDACTED]</p><p>2nd Floor</p><p>PLANTATION, FL 33324</p><p>[REDACTED]</p></td><td/><td>Discharge Disposition: Home or Self Care - 01</td></tr><tr ID="encounter37" class="xRowNormal"><td>[REDACTED]  9:50 AM EDT</td><td ID="encounter37type">Office Visit</td><td><p>UHealth Breast Oncology at Plantation</p><p>[REDACTED]</p><p>2nd Floor</p><p>PLANTATION, FL 33324</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>3rd Floor</p><p>Plantation, FL 33324-3279</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter36" class="xRowAlt"><td>[REDACTED] 10:45 AM EDT</td><td ID="encounter36type">Appointment</td><td><p>UHealth Comprehensive Treatment Unit at Plantation</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td/><td>Discharge Disposition: Home or Self Care - 01</td></tr><tr ID="encounter35" class="xRowNormal"><td>[REDACTED]  1:30 PM EDT</td><td ID="encounter35type">Appointment</td><td><p>UHealth Imaging Services at Plantation</p><p>[REDACTED]</p><p>[REDACTED] DB</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>3rd Floor</p><p>Plantation, FL 33324-3279</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Discharge Disposition: Home or Self Care - 01</td></tr><tr ID="encounter34" class="xRowAlt"><td>[REDACTED]  2:00 PM EDT</td><td ID="encounter34type">Appointment</td><td><p>UHealth Imaging Services at Plantation</p><p>[REDACTED]</p><p>2nd floor, Ste 2500 DB</p><p>PLANTATION, FL 33324</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>3rd Floor</p><p>Plantation, FL 33324-3279</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure41"><td><span class="content_span">Cancer antigen 15-3</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of central portion of right breast in female, estrogen receptor positive (CMS/HCC)</p><p>Malignant neoplasm of breast in female, estrogen receptor positive, unspecified laterality, unspecified site of breast (CMS/HCC)</p><p>Invasive ductal carcinoma of right breast in female (CMS/HCC)</p></td><td ID="procedure41schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr><tr ID="procedure42"><td><span class="content_span">Cancer antigen 27.29</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of central portion of right breast in female, estrogen receptor positive (CMS/HCC)</p><p>Malignant neoplasm of breast in female, estrogen receptor positive, unspecified laterality, unspecified site of breast (CMS/HCC)</p><p>Invasive ductal carcinoma of right breast in female (CMS/HCC)</p></td><td ID="procedure42schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr><tr ID="procedure43"><td><span class="content_span">CEA</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of central portion of right breast in female, estrogen receptor positive (CMS/HCC)</p><p>Malignant neoplasm of breast in female, estrogen receptor positive, unspecified laterality, unspecified site of breast (CMS/HCC)</p><p>Invasive ductal carcinoma of right breast in female (CMS/HCC)</p></td><td ID="procedure43schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Results</a></h3><div><ul><li>(ABNORMAL) Comprehensive metabolic panel ([REDACTED]  9:46 AM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp1Name">Glucose</td><td>87</td><td>65 - 99 mg/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp2Name">Sodium</td><td>142</td><td>135 - 146 mmol/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp3Name">Potassium</td><td><span class="content_span">4.2</span></td><td>3.3 - 5.3 mmol/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp3Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">Serum adult reference range: 3.5-5.5 mmol/L</span></content></td></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp4Name">Chloride</td><td>107</td><td>98 - 110 mmol/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp5Name">CO2</td><td>30</td><td>19 - 34 mmol/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp6Name">Anion Gap</td><td><span class="xflagData">5</span><span class="xflagData"> (L)</span></td><td>6 - 22</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp7Name">BUN</td><td>20</td><td>8 - 23 mg/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp8Name">Osmolality Calculation</td><td>285</td><td>275 - 295 mOsm/kg</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp9Name">Creatinine</td><td>0.79</td><td>0.40 - 1.10 mg/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp10Name">Calcium, Serum</td><td>9.7</td><td>8.6 - 10.3 mg/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp11Name">Protein, Total</td><td><span class="xflagData">6.4</span><span class="xflagData"> (L)</span></td><td>6.6 - 8.7 g/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp11Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><span class="content_span">Serum adult reference range: 6.1-8.1 g/dL</span></content></td></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp12Name">Albumin</td><td>3.9</td><td>3.5 - 5.2 g/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp13Name">Bilirubin, Total</td><td>0.3</td><td>0.0 - 1.2 mg/dL</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp14Name">AST (SGOT)</td><td>12</td><td>10 - 40 U/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp15Name">ALT (SGPT)</td><td>6</td><td>0 - 33 U/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp16Name">Alkaline Phosphatase, S</td><td>89</td><td>35 - 130 U/L</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp17Name">eGFR FAS-EKFC</td><td>61</td><td>&gt;60 mL/min/1.73m2</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp18Name">eGFR CKD-EPI</td><td><span class="content_span">74</span></td><td>&gt;60 mL/min/1.73m2</td><td/><td>[REDACTED] 10:34 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Comp18Signature"/></tr><tr class="xRowAlt xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Two updated equations for the estimated glomerular filtration rate (eGFR) based on age and birth sex are provided.<br/>The [REDACTED] CKD-EPI equation, which correlates closely with the previously used race-based CKD EPI eGFR equation, is used for ages [REDACTED] and older.<br/>This estimate may be needed for US based medical research. <br/>The FAS-EKFC is the current Full Age Spectrum eGFR for ages [REDACTED] and older, developed by a European consortium.<br/>For both equations, the estimated creatinine clearance in mL/min is normalized by body surface of 1.73m2, and the reference interval is &gt;60 ml/min.<br/>Values &gt;90 ml/min are reported as such.  Blood creatinine concentrations are strongly correlated with whole body muscle mass.<br/>Interpret with caution in patients with abnormal body composition (extreme obesity, cachexia, paralysis, amputation) or those with unstable kidney function.<br/>Clinical correlation is recommended when interpreting creatinine based eGFR.<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.Specimen">Serum</td><td/><td/><td>[REDACTED]  9:46 AM EDT</td><td>[REDACTED] 10:13 AM EDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107034.PerformingLab"><p>[REDACTED] &amp; CLINICS - PLANTATION</p></td><td><p>CLIA#10D2036991</p><p>[REDACTED]</p><p>Suite 1000</p></td><td><p>Plantation, FL 33324</p></td><td><p>[REDACTED]</p></td></tr><tr><td><p>UMHC - PLANTATION</p></td><td><p>[REDACTED]</p><p>SUITE 1000</p></td><td><p>PLANTATION</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) CBC and differential ([REDACTED]  9:46 AM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp1Name">White Blood Cells, Total</td><td>5.5</td><td>4.0 - 10.5 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp2Name">RBC</td><td>4.17</td><td>3.8 - 4.9 10*6/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp3Name">Hemoglobin</td><td>11.8</td><td>11.1 - 14.6 g/dL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp4Name">Hematocrit</td><td>37.7</td><td>33.2 - 43.4 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp5Name">MCV</td><td>90.4</td><td>80 - 100 fL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp6Name">MCH</td><td>28.3</td><td>26.5 - 31.7 pg</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp7Name">MCHC</td><td><span class="xflagData">31.3</span><span class="xflagData"> (L)</span></td><td>32 - 35.2 g/dL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp8Name">RDW</td><td>14.0</td><td>11 - 15 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp9Name">Platelet Count</td><td>240</td><td>140 - 400 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp10Name">MPV</td><td>11.0</td><td>9.4 - 16.4 fL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp11Name">Nucleated RBC, Percent</td><td>0</td><td>0 /100WBC</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp12Name">Diff Type</td><td>AUTO</td><td/><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp13Name">Neutrophils, Percent</td><td>58.7</td><td>36 - 70 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp14Name">Lymphocytes, Percent</td><td>25.1</td><td>16 - 43 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp15Name">Monocytes, Percent</td><td>11.9</td><td>6 - 12 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp16Name">Eosinophils, Percent</td><td>2.8</td><td>0 - 5 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp17Name">Basophils, Percent</td><td>1.1</td><td>0 - 1.2 %</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp18Name">Neutrophils, Absolute</td><td>3.20</td><td>2.0 - 6.0 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp19Name">Lymphocytes, Absolute</td><td>1.37</td><td>1.1 - 2.7 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp19Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp20" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp20Name">Immature Granulocytes, Percent</td><td>0.4</td><td>%</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp20Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp21" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp21Name">Immature Granulocytes, Absolute</td><td>0.02</td><td>10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp21Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp22" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp22Name">Absolute Monocyte</td><td>0.65</td><td>0.15 - 1.00 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp22Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp23" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp23Name">Absolute Basophils</td><td>0.06</td><td>0.01 - 0.20 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp23Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp24" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp24Name">Absolute Eosinophils</td><td>0.15</td><td>0.10 - 0.50 10*3/uL</td><td/><td>[REDACTED] 10:16 AM EDT</td><td>UMHC - PLANTATION</td><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Comp24Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.Specimen">Whole Blood</td><td>VENOUS STRUCTURE / Unknown</td><td/><td>[REDACTED]  9:46 AM EDT</td><td>[REDACTED] 10:13 AM EDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.255107033.PerformingLab"><p>[REDACTED] &amp; CLINICS - PLANTATION</p></td><td><p>CLIA#10D2036991</p><p>[REDACTED]</p><p>Suite 1000</p></td><td><p>Plantation, FL 33324</p></td><td><p>[REDACTED]</p></td></tr><tr><td><p>UMHC - PLANTATION</p></td><td><p>[REDACTED]</p><p>SUITE 1000</p></td><td><p>PLANTATION</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Malignant neoplasm of central portion of right breast in female, estrogen receptor positive (CMS/HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">Malignant neoplasm of breast in female, estrogen receptor positive, unspecified laterality, unspecified site of breast (CMS/HCC)</span></p></td></tr><tr ID="vdx6" class="xRowNormal"><td><p><span class="content_span">Invasive ductal carcinoma of right breast in female (CMS/HCC)</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%" span="2"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED] 10:26 AM EDT</td></tr><tr class="xRowAlt"><td ID="assessment2">A fall risk assessment has been completed for the patient</td><td>[REDACTED] 10:26 AM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id11" href="#toc">Care Teams</a></h3><div><table ID="ct53"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>